RBP4 and Insulin resistance: Dysregulation of RBP4 affects both muscle types, leading to insulin resistance in skeletal muscle and contributing to cardiac remodeling, hypertrophy, and dysfunction (Nono and Blüher, 2021; Li et al., 2024; Ji et al., 2022; Schiborn et al., 2022).